<DOC>
	<DOCNO>NCT01252550</DOCNO>
	<brief_summary>The purpose study investigate association gut microbiota , immunology typical pathophysiological factor patient IBS ( subtypes ) AND assess effect Activia consumption GI symptom provoke lactulose challenge test IBS patient .</brief_summary>
	<brief_title>Effects Activia IBS</brief_title>
	<detailed_description>BACKGROUND There wide variety symptom IBS , irritable bowel syndrome , among individual symptom specific individual . Pathophysiological factor importance identify IBS , factor occur symptomatology patient . Visceral hypersensitivity , deviant motor secretion function gastrointestinal tract well psychological factor believe importance . However relative importance specific factor symptomatology elucidate . Deviations autonomic central nerve function also demonstrate IBS , along low grad inflammation , immunological anomaly , change microbiological gut flora . The importance factor develop established pathophysiological factor , visceral hypersensitivity , deviate gastrointestinal motor secretion function yet study . Neither interaction autonomic central nerve function significance function IBS . In response recent finding , regard deviant microbiological gut flora IBS , use probiotic treatment test , alter outcome . The effect product positive , far patient IBS get sufficient relief . The response treatment probiotic predict method available today ; example possible predict patient respond treatment mechanism behind symptom relief . Questions - What affect symptomatology IBS ? - Visceral hypersensitivity - Deviant colonic motor function - Autonomic nerve dysfunction - Central nerve dysfunction ( especially level brain stem ) - Psychological factor - Coping - Demography ( sex , age ) - Immunological deviation peripheral blood/intestine - Deviations composition microbiological gut flora - Sexual/physical abuse - What interactions pathophysiological deviation IBS ? - Can treatment response probiotic predict ? - Why probiotic give relief patient IBS ? INVESTIGATION 1 . A structured investigational model , cover important pathophysiological factor IBS clarify symptomatology patient detail . 2 . A randomized , double blind placebo control study , evaluate effect probiotic ( Bifidobacterium lactis ) symptomatology IBS well measure effect probiotic fermentation intestine , immunological variable composition microbiological gut flora . VISIT 1 - The patient thoroughly inform regard context study write consent sign . - Blood sample take rule organic disease ( Hb , LPK , TPK , Na , K , Crea , Liver status , CRP , Transglutaminase antibodies ) . - Validated questionnaire complete - IBS Symptom Severity Scale ( IBS-SSS ) - gastrointestinal extra intestinal symptom - Gastrointestinal Symptom Rating Scale - IBS ( GSRS-IBS ) - IBS specific GI-symptoms - Hospital Anxiety Depression Scale ( HAD ) - general anxiety depression - Visceral Sensitivity Index ( VSI ) - GI-specific anxiety - Patient Health Questionnaire-15 ( PHQ-15 ) - severity somatisation , depression , anxiety ( panic anxiety , eat disorder alcohol problem ) - IBS Quality Life Questionnaire ( IBSQOL ) - disease specific health relate quality life - Fatigue Impact Scale ( FIS ) - impact fatigue quality life - Abuse Questionnaire - physical sexual abuse - Sense Coherence Index - sense coherence , cop - ABR ( Auditory Brain stem Response audiometry ) - brain stem audiometry measure electric activity level brain stem listen different audio stimulus ( listen sound click headphone ) . Through test function brain stem measure , ability mask effect disturb noise etc . - Holter-ECG ( 24 h ) - spectrum analysis evaluate autonomic nerve function ; balance parasympathetic sympathetic nerve function . - Permeability test intestine - patient drink liquid solution water sugar ( 50.0 g sucrose , 5.0 g mannitol , 10.0 g lactulose 1.0 g sucralose 200 ml tap water ) , thereafter urine collect follow 9 h. The amount sugar find urine measurement permeability intestine . The urine collect separate container depend time day , depend time permeability small intestine respectively large intestine measure separately . - Registration stool consistency frequency follow 2-3 week , visit 3 , use `` Bristol Stool Form Scale '' ( BSF ) - Food journal hand - food intake three consecutive day register patient . VISIT 2 - Handing urine - last urine collect visit 1 hand patient . - Returning EKG-material - Holter , record EKG , return patient . VISIT 3 - Salivary sample - test measure level cortisol , important stress marker . - Oro-anal transit time - 60 marker see x-ray examination swallow prior visit ( 10 markers/day 6 day ) examination possible see many marker remain GI-tract tract position . This way measure oro-anal transit time , mainly determine colonic transit time . Thereby indirect measurement motor function colon . Regional transit different colonic part assess evaluate colon marker . - Rectal sensitivity test - balloon place rectum tube attach call barostat . By use barostat possible inflate deflate balloon control matter also measure compression volume balloon . The compression volume increase predetermined way patient ask state feel use VAS-scales ; symptom note intensity symptom . The sensitivity rectum ( large intestine ) describe value level compression volume give rise symptom . VISIT 4 - Sigmoidoscopy biopsy . Macroscopic evaluation mucosa large intestine , rule inflammatory bowel disease cause patient symptom . Biopsies rectum sigmoid collect analyzed regard inflammatory cell population interleukins colonic mucosa , well amount bacteria mucosa . Molecular technique use , 16sRNA . - Stool sample - analysis immunological inflammatory marker faeces composition microbiological bacterial flora , reflect luminal bacterial flora ( 16sRNA technique use ) . - Blood sample - various immunological analysis , example different pro- anti-inflammatory interleukin different food relate antibody ( IgE , IgG ) , do evaluate toe immunological activity propensity react unfavorable way instance consume certain food item . - Symptom protocol ( IBS-SSS ) journal stool consistency frequency ( Bristol Stool Form Scale ( BSF ) ) hand . Symptoms stool register 1-3 week use basal value prior treatment period . VISIT 5 - Lactulose challenge test - evaluation symptom excretion hydrogen methane gas exhale air intake liquid meal ( 400ml Nutridrink® , 1.5 kcal/ml ) contain 25 mg lactulose . Hydrogen methane gas exhale air measurement degree fermentation intestine , indirectly bacterial overgrowth small intestine detect . This `` challenge '' test physiological test study sensitivity GI-tract . The symptoms excretion gas register 4 h. - Stool sample - analysis immunological inflammatory marker faeces composition microbiological bacterial flora , reflect luminal bacterial flora ( 16sRNA technique use ) . - Salivary sample - test measure level cortisol , important stress marker . - Randomization patient include treatment part study . The patient 14 day daily intake yoghurt contain probiotic ( Bifidobacterium lactis , Activia® ) yoghurt without probiotic ( placebo ) , 125 g 2 time day ( morning evening ) . During treatment part patient register symptom ( Symptom protocol ( IBS-SSS ) ) stool consistency frequency ( Bristol Stool Form Scale ( BSF ) ) . VISIT 6 - Visit take place last day treatment period . - Lactulose challenge test repeat evaluate potential difference symptom excretion hydrogen methane gas exhale air intake liquid meal ( 400ml Nutridrink® , 1.5 kcal/ml ) contain 25 mg lactulose . - Stool sample - analysis immunological inflammatory marker faeces composition microbiological bacterial flora , reflect luminal bacterial flora ( 16sRNA technique use ) . - Blood sample - various immunological analysis , example different pro- anti-inflammatory interleukin different food relate antibody ( IgE , IgG ) , do evaluate toe immunological activity propensity react unfavorable way instance consume certain food item . Will compare previous blood sample . VISIT 7 • Summarizing visit - visit doctor specialize functional GI-disorders . The result test analysis previous visit evaluate potential treatment base result . The patient offer telephone base follow-up want , otherwise recommit primary health care .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Signed write informed consent Age : 18 65 year old baseline visit IBS accord Rome III criterion Ability understand willingness comply study procedure Participation another clinical study 1 month prior screen visit throughout study Abnormal result screen laboratory test clinically relevant study participation Other gastrointestinal disease ( ) explain patient 's symptom , judge investigator Other severe disease ( ) malignancy , severe heart disease , kidney disease neurological disease Symptoms indicate severe disease ( ) gastrointestinal bleeding , weight loss fever Severe psychiatric disease Previous history drug alcohol abuse 6 month prior screen Intolerance allergy milk product gluten Use probiotic product ( accord sponsor 's list ) 2 week prior study throughout study Consumption antibiotic 1 month prior screen throughout study Consumption cortisone , NSAID antiinflammatory drug regular basis 2 week prior screen throughout study Pregnant lactate wish become pregnant period study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>IBS</keyword>
	<keyword>GI</keyword>
	<keyword>QOL</keyword>
	<keyword>Pathophysiology</keyword>
	<keyword>Gut microbiota</keyword>
	<keyword>Danone</keyword>
	<keyword>Activia</keyword>
	<keyword>Probiotics</keyword>
</DOC>